gvtcx

PHE_Scientific Provision for purchase of NextSeq Paltforms for Genomic expansion

Public Health England Published 29 Apr 2021 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£697,788
Statuscomplete
Category (CPV) 33000000 +1 more
Deadline21 Apr 2021
Contract start23 Apr 2021
Contract end22 Apr 2022
Procedureselective
SME suitableYes
OCIDocds-b5fd17-51f4e640-f403-4811-ac7c-3164aa85062d

Award

SupplierValueDateStatus
Illumina Cambridge Ltd £697,788 20 Apr 2021 active

description

PHE has awarded a contract to Illumina Cambridge Ltd via direct award under the PHE Microbiology Framework Lot 2.

The contract is for the Provision for purchase of NextSeq Paltforms in aim to increase and support the strategy for COVID 19 sequencing and analysis capacity under genomic expansion for COG UK consortium.

It is a PHE wide contract.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
29 Apr 2021 Award (award) · 3b1dee3c-77f8-4147-8173-6d4db44eadbd-432562

more from Public Health England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.